lactic acid has been researched along with Neuroretinitis in 2 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The therapeutic effects of betamethasone phosphate (BP) encapsulated in biocompatible and biodegradable blended nanoparticles of poly(lactic acid) (PLA) homopolymers and PEG-block-PLA copolymers (stealth nanosteroids) were examined in an experimental autoimmune uveoretinitis (EAU) model in Lewis rats." | 7.77 | Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis. ( Akiyama, G; Higaki, M; Ishihara, T; Sakai, T; Tsuneoka, H, 2011) |
| " In this study, we evaluated the effects of intravenously administered poly(lactic acid) nanoparticles encapsulating betamethasone phosphate (BP-PLA NPs) on experimental autoimmune uveoretinitis (EAU) in Lewis rats." | 7.73 | Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. ( Higaki, M; Ishihara, T; Kitahara, K; Kohno, H; Matsushima, M; Mizushima, Y; Saito, S; Sakai, T, 2006) |
| "The therapeutic effects of betamethasone phosphate (BP) encapsulated in biocompatible and biodegradable blended nanoparticles of poly(lactic acid) (PLA) homopolymers and PEG-block-PLA copolymers (stealth nanosteroids) were examined in an experimental autoimmune uveoretinitis (EAU) model in Lewis rats." | 3.77 | Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis. ( Akiyama, G; Higaki, M; Ishihara, T; Sakai, T; Tsuneoka, H, 2011) |
| " In this study, we evaluated the effects of intravenously administered poly(lactic acid) nanoparticles encapsulating betamethasone phosphate (BP-PLA NPs) on experimental autoimmune uveoretinitis (EAU) in Lewis rats." | 3.73 | Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. ( Higaki, M; Ishihara, T; Kitahara, K; Kohno, H; Matsushima, M; Mizushima, Y; Saito, S; Sakai, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakai, T | 2 |
| Ishihara, T | 2 |
| Higaki, M | 2 |
| Akiyama, G | 1 |
| Tsuneoka, H | 1 |
| Kohno, H | 1 |
| Saito, S | 1 |
| Matsushima, M | 1 |
| Mizushima, Y | 1 |
| Kitahara, K | 1 |
2 other studies available for lactic acid and Neuroretinitis
| Article | Year |
|---|---|
Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.
Topics: Animals; Autoimmune Diseases; Betamethasone; Biocompatible Materials; Biological Availability; Delay | 2011 |
Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Betamethasone; Choroid; Delayed-Action Prepa | 2006 |